Health
Novel protection pathway makes cells resistant to viral infection – Drug Target Review
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Posted: 28 August 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Researchers have discovered a new cellular protection mechanism which they demonstrated can prevent viruses, including Ebola and coronaviruses like SARS-CoV-2, from infecting cells. According to the collaborators, the new understanding surrounding cellular mechanisms in…
-
Business21 hours agoThe ultimate Australian stocks to buy and hold for 10+ years
-
General23 hours ago‘Hidden and radical’ power of First Nations women unlocked in big hART’s Punkaliyarra project
-
Noosa News23 hours agoVictorian sheep farmer makes breakthrough in bid to breed footrot-resistant sheep
-
Noosa News22 hours agoNew process turns wheat straw and oat husks into sustainable clothing